Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors

Acta Oncologica

Volumn 48, Issue 3, 2009, Pages 475-476

  Cheng, Elaine ^a   Berthold, Dominik R ^a   Moore, Malcolm J ^a   Duran, Ignacio ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CLOPIDOGREL; ETOPOSIDE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; ANTINEOPLASTIC AGENT;

ADULT; ARTERY THROMBOSIS; BLOOD CLOT LYSIS; CASE REPORT; FOOT PAIN; GERM CELL TUMOR; HUMAN; LEG SWELLING; LETTER; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SEMINOMA; TESTIS CANCER; THROMBOEMBOLISM; THROMBOSIS; CHEMICALLY INDUCED DISORDER; EMBRYONAL CARCINOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROPERITONEAL TUMOR; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, EMBRYONAL; CISPLATIN; ETOPOSIDE; HUMANS; MALE; MIDDLE AGED; RETROPERITONEAL NEOPLASMS; SEMINOMA; TESTICULAR NEOPLASMS; THROMBOSIS; TREATMENT OUTCOME;

EID: 70350678999     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802446779     Document Type: Letter

References (16)

1. De Vita VJ Jr HS, SA R. Cancer: Principles and practice of oncology. 6th ed. Philadelphia P.A: Lippincott-Raven; 2001
2. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242-53.
3. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001;102: V215-V224.
4. Cool RM, Herrington JD, Wong L. Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide. Pharmacotherapy 2002;22:1200-4.
5. Hennessy B, O'Connor M, Carney DN. Acute vascular events associated with cisplatin therapy in malignant disease. Ir Med J 2002;95:145-6, 148.
6. Czaykowski PM, Moore MJ, Tannock IF. High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol 1998;160:2021-4.
7. Longo F, Mansueto G, Poggi A, Pellegrini P, Falzetta A, Rozzi A, et al. Acute arterial thrombosis in a patient with small cell lung cancer after a cycle of chemotherapy with cisplatin and etoposide. Tumori 1999;85:214-5.
8. Apiyasawat S, Wongpraparut N, Jacobson L, Berkowitz H, Jacobs LE, Kotler MN. Cisplatin induced localized aortic thrombus. Echocardiography 2003;20:199-200.
9. Bayne MC. Chemotherapy associated arterial thrombosis. Clin Oncol (R Coll Radiol) 2002;14:261-2.
10. Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, et al. Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature. J Clin Oncol 2000;18:2169-78.
11. Cantwell BM, Mannix KA, Roberts JT, Ghani SE, Harris AL. Thromboembolic events during combination chemotherapy for germ cell-malignancy. Lancet 1988;2: 1086-7.
12. Piketty AC, Fléchon A, Laplanche A, Nouyrigat E, Droz JP, Théodore C, et al. The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area. Br J Cancer 2005;93:909-14.
13. Illarramendi JJ, Gallego J. Cisplatin-based chemotherapy and acute cerebrovascular events. Lancet 1991;338:705.
14. Boyer M, Raghavan D, Harris PJ, Lietch J, Bleasel A, Walsh JC, et al. Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 1990;8:21-6.
15. Nichols CR, Roth BJ, Williams SD, Gill I, Muggia FM, Stablein DM, et al. No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: An analysis of the Testicular Cancer Intergroup Study. J Clin Oncol 1992;10:760-5.
16. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, et al. American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007;25:5490-505. (Pubitemid 350232226)